Rimini Hospital

Rimini 47923

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Gastric Adenocarcinoma, Gastric Cancer

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer — Completed